A new diagnostic algorithm for pattern-oriented autoantibody testing according to the ICAP nomenclature: A pilot study
- Creators
- Infantino M.
- Carbone T.
- Manfredi M.
- Grossi V.
- Antico A.
- Panozzo M. P.
- Brusca I.
- Alessio M. G.
- Previtali G.
- Platzgummer S.
- Cinquanta L.
- Paura G.
- Deleonardi G.
- Trevisan M. T.
- Radice A.
- Castiglione C.
- Imbastaro T.
- Fabris M.
- Pesce G.
- Porcelli B.
- Terzuoli L.
- Sorrentino M. C.
- Tampoia M.
- Abbracciavento L.
- Villalta D.
- Conte M.
- Barberio G.
- Gallo N.
- Benucci M.
- Bizzaro N.
- Others:
- Infantino, M.
- Carbone, T.
- Manfredi, M.
- Grossi, V.
- Antico, A.
- Panozzo, M. P.
- Brusca, I.
- Alessio, M. G.
- Previtali, G.
- Platzgummer, S.
- Cinquanta, L.
- Paura, G.
- Deleonardi, G.
- Trevisan, M. T.
- Radice, A.
- Castiglione, C.
- Imbastaro, T.
- Fabris, M.
- Pesce, G.
- Porcelli, B.
- Terzuoli, L.
- Sorrentino, M. C.
- Tampoia, M.
- Abbracciavento, L.
- Villalta, D.
- Conte, M.
- Barberio, G.
- Gallo, N.
- Benucci, M.
- Bizzaro, N.
Description
The commercial tests currently available as second-level tests to detect ANA sub-specificities are generally used independently from the ANA immunofluorescence (IIF) pattern. The aim of this study was to evaluate the efficacy of the use of a customizable pattern-oriented antigenic panel by immunoblot (IB) using the International Consensus on ANA Patterns (ICAP) classification scheme, in order to introduce a novel and updated autoimmune diagnostic flowchart. 710 sera referred for routine ANA testing were selected on the basis of the ANA pattern according to the ICAP nomenclature (nuclear speckled AC-2,4,5; nucleolar AC-8,9,10,29; cytoplasmic speckled AC-18,19,20) and on an IIF titer ≥1:320. They were then assayed by three experimental IB assays using a panel of selected antigens. ICAP-oriented IB detected 515 antibody reactivities vs. 457 of traditional anti-ENA in the nuclear speckled pattern group, 108 vs. 28 in the nucleolar pattern group, and 43 vs. 34 in the cytoplasmic speckled pattern. This pilot study may lead the way for a new approach introducing an ICAP pattern-oriented follow up testing as a valid alternative to the existing standard panels, thus enabling more patients with autoimmune rheumatic disease to be accurately diagnosed.
Additional details
- URL
- http://hdl.handle.net/11567/1024057
- URN
- urn:oai:iris.unige.it:11567/1024057
- Origin repository
- UNIGE